Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone ...

The FDA's decision comes despite mixed results in clinical trials of the drug as an adjunctive treatment for depression ... Sage Therapeutics/Biogen's GABA A receptor modulator zuranolone ...